Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials

A. K. Brimhall, L. N. King, J. C. Licciardone, H. Jacobe, A. Menter

Research output: Contribution to journalReview articlepeer-review

112 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

Medicine & Life Sciences